Heartflow Reports Third Quarter 2025 Financial Results

Impact · against what's priced in

Heartflow exhibits strong operational momentum with 41% year-over-year revenue growth and an improving path toward break-even. The removal of future noncash warrant volatility and a strengthened balance sheet post-IPO provide further fundamental support.

HTFL+0.50

No priced-in read yet

In context

The company's 41% YoY revenue growth to $46.3 million and the issuance of full-year guidance ($173.0M-$173.5M) demonstrate strong scalability. Furthermore, the full exercise of warrants eliminates future noncash volatility, and the $291.2 million cash position significantly reduces financial risk.

Read from the article alone

• ipo▲34%
• earnings▲7%
• guidance
• ai
• healthcare
• HTFL
• biotechnology
• medical devices